DK3541359T3 - Tablet omfattende separat bindemiddel og erythritol - Google Patents

Tablet omfattende separat bindemiddel og erythritol Download PDF

Info

Publication number
DK3541359T3
DK3541359T3 DK17783711.9T DK17783711T DK3541359T3 DK 3541359 T3 DK3541359 T3 DK 3541359T3 DK 17783711 T DK17783711 T DK 17783711T DK 3541359 T3 DK3541359 T3 DK 3541359T3
Authority
DK
Denmark
Prior art keywords
erythritol
table including
including separate
separate binder
binder
Prior art date
Application number
DK17783711.9T
Other languages
English (en)
Inventor
Helle Wittorff
Original Assignee
Fertin Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/356,175 external-priority patent/US10543205B2/en
Priority claimed from PCT/DK2016/050377 external-priority patent/WO2018091048A1/en
Application filed by Fertin Pharma As filed Critical Fertin Pharma As
Application granted granted Critical
Publication of DK3541359T3 publication Critical patent/DK3541359T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK17783711.9T 2016-11-18 2017-10-13 Tablet omfattende separat bindemiddel og erythritol DK3541359T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/356,175 US10543205B2 (en) 2016-11-18 2016-11-18 Oral delivery vehicle containing nicotine
PCT/DK2016/050377 WO2018091048A1 (en) 2016-11-18 2016-11-18 Oral delivery vehicle
PCT/DK2017/050342 WO2018091050A1 (en) 2016-11-18 2017-10-13 Tablet comprising separate binder and erythritol

Publications (1)

Publication Number Publication Date
DK3541359T3 true DK3541359T3 (da) 2021-02-22

Family

ID=60083055

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17783711.9T DK3541359T3 (da) 2016-11-18 2017-10-13 Tablet omfattende separat bindemiddel og erythritol

Country Status (14)

Country Link
EP (2) EP3541360A1 (da)
JP (2) JP7297666B2 (da)
KR (1) KR102582802B1 (da)
CN (2) CN109952092B (da)
AU (4) AU2017360584B2 (da)
BR (2) BR112019008138A2 (da)
CA (2) CA3044382A1 (da)
DK (1) DK3541359T3 (da)
ES (1) ES2860802T3 (da)
MA (1) MA46822A (da)
MX (2) MX2019005928A (da)
PL (1) PL3541359T3 (da)
RU (1) RU2736072C1 (da)
WO (2) WO2018093501A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10543205B2 (en) 2016-11-18 2020-01-28 Fertin Pharma A/S Oral delivery vehicle containing nicotine
US10632076B2 (en) 2016-11-18 2020-04-28 Fertin Pharma A/S Tablet comprising separate binder and erythritol
BR112020022379A2 (pt) * 2018-05-17 2021-02-02 Fertin Pharma A/S goma de mascar em comprimidos adequada para ingredientes farmacêuticos ativos
US11135157B2 (en) 2018-05-17 2021-10-05 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the throat
US11096896B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Tablet dosage form for buccal absorption of active ingredients
US11090263B2 (en) 2018-05-22 2021-08-17 Fertin Pharma A/S Tableted chewing gum suitable for active pharmaceutical ingredients
US11096894B2 (en) * 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet for induced saliva generation
US20190350858A1 (en) 2018-05-17 2019-11-21 Fertin Pharma A/S Oral tablet for delivery of active ingredients to the gastrointestinal tract
US11052047B2 (en) 2018-05-17 2021-07-06 Fertin Pharma A/S Oral tablet suitable for fast release of active pharmaceutical ingredients
US11058633B2 (en) 2018-05-17 2021-07-13 Fertin Pharma A/S Disintegrating oral tablet suitable for active pharmaceutical ingredients
US11096895B2 (en) 2018-05-17 2021-08-24 Fertin Pharma A/S Oral tablet suitable for active pharmaceutical ingredients
US11058641B2 (en) 2018-05-17 2021-07-13 Fertin Pharma A/S Oral tablet for taste masking of active ingredients
US20210106516A1 (en) * 2019-10-11 2021-04-15 Fertin Pharma A/S Ion-Exchange Composition With Water-Soluble Mucoadhesive Polymers
KR102345862B1 (ko) * 2021-03-18 2022-01-03 김현진 팝핑 성분을 포함하는 고체 구강청결용 조성물

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
US4820506A (en) 1987-05-01 1989-04-11 Research Foundation, State University Of New York Salivary stimulant
TW469135B (en) * 1995-10-03 2001-12-21 Chugai Pharmaceutical Co Ltd Chewable tablet
AU713462B2 (en) * 1996-07-12 1999-12-02 Daiichi Pharmaceutical Co., Ltd. Quickly disintegrable compression-molded materials and process for producing the same
GB9716432D0 (en) * 1997-08-05 1997-10-08 Cerestar Holding Bv Tableting of erythritol
US5874068A (en) 1997-12-08 1999-02-23 Warner-Lambert Company Stabilized antiplaque and antigingivitis oral compositions containing N.sup.α -alkyl-L-arginine alkyl ester salts
WO2000025598A1 (en) 1998-11-03 2000-05-11 Dandy A/S Sucrose fatty acid esters for use as increased release of active ingredients
US6746697B2 (en) * 2000-12-15 2004-06-08 Phytos, Inc. Composition containing Heliopsis longipes root extract and oral carrier
WO2002069934A1 (fr) * 2001-03-06 2002-09-12 Kyowa Hakko Kogyo Co., Ltd. Préparations se délitant rapidement dans la bouche
JP2003125706A (ja) * 2001-10-23 2003-05-07 Lion Corp 口中清涼製剤
US20040101494A1 (en) * 2002-11-26 2004-05-27 Scott Douglas Craig Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth
US20040223921A1 (en) * 2003-05-07 2004-11-11 Rau Allen H. Oral care tablet
KR20070042192A (ko) * 2004-09-02 2007-04-20 더 프록터 앤드 갬블 캄파니 정유를 함유하는 구강 케어 조성물
EP1863466B1 (en) 2005-03-03 2017-08-09 Takasago International Corporation (USA) Synergistic salivation components
JP2006335686A (ja) * 2005-06-02 2006-12-14 Hamari Chemicals Ltd 直打用エリスリトール・ソルビトール混合顆粒の製造方法
CN1709229A (zh) * 2005-06-10 2005-12-21 北京阜康仁生物制药科技有限公司 盐酸美金刚口腔崩解片及其制备方法
US20070077300A1 (en) * 2005-09-30 2007-04-05 Wynn David W Oral compositions containing a salivation inducing agent
CN100446759C (zh) * 2006-10-16 2008-12-31 北京科信必成医药科技发展有限公司 一种天麻素口腔崩解片及其制备方法
JP5766899B2 (ja) * 2007-04-11 2015-08-19 ニプロ株式会社 口腔内崩壊剤及びその製造方法
WO2009007768A1 (en) * 2007-07-06 2009-01-15 Gumlink A/S Compressed tablet comprising polyol
US20100255307A1 (en) * 2007-07-27 2010-10-07 Cargill Inc. Micronization of polyols
PT2334202E (pt) * 2008-09-04 2012-02-28 Cargill Inc Fabrico de comprimidos de eritritol
US9591852B2 (en) 2009-11-23 2017-03-14 Mcneil-Ppc, Inc. Biofilm disruptive compositions
US8658139B1 (en) * 2010-02-27 2014-02-25 Squigle, Inc. Prevention and treatment of oral diseases
WO2013125350A1 (ja) * 2012-02-23 2013-08-29 フロイント産業株式会社 口腔内崩壊錠用直打賦形剤及びその製造方法、並びに口腔内崩壊錠
JP6266891B2 (ja) * 2013-03-29 2018-01-24 株式会社ロッテ 口腔内洗浄用組成物
US10357054B2 (en) * 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
WO2015158637A1 (en) * 2014-04-17 2015-10-22 Unilever Plc Solid oral care compositions
EP3206671B1 (en) * 2014-10-16 2024-06-12 Cargill, Incorporated Process for preparing a directly compressible erythritol and uses thereof
US9975847B2 (en) 2014-11-11 2018-05-22 Johnson & Johnson Consumer Inc. Amino acid derivatives and their uses
CN104546807B (zh) * 2015-01-21 2020-09-01 齐鲁制药有限公司 奥氮平口腔速溶膜剂

Also Published As

Publication number Publication date
JP7297666B2 (ja) 2023-06-26
CN110087634A (zh) 2019-08-02
AU2017360378A1 (en) 2019-06-06
RU2019118433A (ru) 2020-12-18
AU2017360584A1 (en) 2019-05-02
KR102582802B1 (ko) 2023-10-06
MX2019005828A (es) 2019-07-08
MX2019005928A (es) 2019-11-12
AU2023214357A1 (en) 2023-08-31
PL3541359T3 (pl) 2021-05-31
BR112019010115A8 (pt) 2022-07-26
EP3541359B1 (en) 2021-01-27
KR20190086512A (ko) 2019-07-22
JP2019535729A (ja) 2019-12-12
RU2736072C1 (ru) 2020-11-11
WO2018093501A1 (en) 2018-05-24
EP3541359A1 (en) 2019-09-25
CA3040830C (en) 2021-06-15
WO2018091050A1 (en) 2018-05-24
JP2019535732A (ja) 2019-12-12
CA3044382A1 (en) 2018-05-24
BR112019008138A2 (pt) 2019-07-02
CN109952092A (zh) 2019-06-28
AU2021200826B2 (en) 2022-02-17
CN109952092B (zh) 2022-08-23
ES2860802T3 (es) 2021-10-05
CA3040830A1 (en) 2018-05-24
JP6840849B2 (ja) 2021-03-10
BR112019010115A2 (pt) 2019-08-20
MA46822A (fr) 2019-09-25
EP3541360A1 (en) 2019-09-25
AU2017360584B2 (en) 2020-12-17
AU2021200826A1 (en) 2021-03-04
RU2019118433A3 (da) 2020-12-18

Similar Documents

Publication Publication Date Title
DK3541359T3 (da) Tablet omfattende separat bindemiddel og erythritol
IL279263A (en) A non-flammable smoking device and its components
DK3303379T3 (da) Tigit-bindende midler og anvendelser deraf
DK3354282T3 (da) Glycan-terapeutiske midler og relaterede fremgangsmåder deraf
IL259090A (en) A non-flammable smoking device and its components
DK3310371T3 (da) Glucagon og GLP-1-Co-agonistforbindelser
DK3169741T3 (da) Forbedrede bindemiddelsammensætninger og anvendelser deraf
DK3126381T4 (da) Claudin-6-specifikke immunoreceptorer og t-celleepitoper
DK3302431T3 (da) Taxanpartikler og anvendelse deraf
DK3189081T3 (da) Cd123-bindende midler og anvendelser deraf
DK3210977T3 (da) Hidtil ukendt aminoalkylbenzothiazepinderivat og anvendelse deraf
DK3357513T3 (da) Farmaceutisk sammensætning og anvendelse deraf
DK3352879T3 (da) Filterindsats og en filteranordning
DK3149015T3 (da) Minimale saponin-analoger, syntese og anvendelse deraf
PL3720418T3 (pl) Tabletka nikotynowa
IL259088A (en) A non-flammable smoking device and its components
DK3283058T3 (da) Ribociclib-tablet
DK3373937T3 (da) Anti-cd22-antistof-maytansin-konjugater og fremgangsmåder til anvendelse deraf
IL267389A (en) A sheet containing nicotine and a binder
KR20180084810A (ko) 정제 세트
DK3386956T3 (da) Fumagillolderivater og polymorfer deraf
DK3365321T3 (da) Solabegron-zwitterion og anvendelser deraf
DK3321279T3 (da) Exenatidmodificeringsmiddel og anvendelse deraf
DK3388085T3 (da) Farmaceutisk sammensætning og anvendelser deraf
DK3337506T3 (da) Kombinationer og anvendelser deraf